文献速递神经核医学

不同原发性进行性失语表型中的淀粉样蛋白PET阳性

Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes.
PubMed 文献 · Clin Nucl Med · 2018-01-01

这项描述性回顾性研究对12例原发性进行性失语(PPA)患者行氟比他班PET,8例(66.7%)淀粉样蛋白阳性,其中非流利型5例中4例阳性、语义型3例中1例阳性、无法分类3例中2例阳性、少词型1例阳性;PPA阳性患者氟比他班摄取在除后扣带和颞叶皮质外各感兴趣区均高于典型遗忘型阿尔茨海默病患者。

要点

  • 12例PPA中8例(66.7%)氟比他班PET淀粉样蛋白阳性。
  • 非流利型PPA 5例中4例阳性,语义型PPA 3例中1例阳性。
  • PPA阳性者氟比他班摄取除后扣带和颞叶皮质外各感兴趣区均高于典型AD。

核心结论

  • 结果提示氟比他班PET或可用于常规临床流程,以提高识别PPA综合征不同临床亚型患者中阿尔茨海默病病理的可靠性。

研究设计与样本

  • 描述性回顾性PET研究,纳入12例右利手PPA患者(语义型3例、非流利型5例、少词型1例、无法分类3例),并与11例典型遗忘型阿尔茨海默病患者比较。

主要发现

  • 12例PPA中8例(66.7%)判定为淀粉样蛋白阳性。
  • 语义型PPA 3例中1例氟比他班阳性,非流利型PPA 5例中4例阳性,无法分类3例中2例阳性,少词型PPA 1例阳性。
  • PPA氟比他班阳性患者氟比他班摄取显著高于典型阿尔茨海默病患者,差异见于除后扣带和颞叶皮质外的所有感兴趣区。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Primary progressive aphasia (PPA) is a neurological syndrome in which language functions become progressively impaired with relative sparing of memory and other instrumental functions. The pathologic causes of PPA are heterogeneous, but studies suggest that logopenic PPA (LPA) is underpinned by Alzheimer disease (AD) pathology in a high proportion of cases. The purposes of this descriptive and retrospective study were to characterize F-florbetapir PET imaging in a group of patients with a clinical syndrome of PPA, to determine the value of clinical characterization based on language phenotype in predicting the underlying pathology of PPA with F-florbetapir, and to quantify amyloid load in PPA subjects classified as "positive" F-florbetapir scans. Then, we compare the quantification and distribution of F-florbetapir uptake with those of typical, predominantly amnestic AD patients. METHODS: We conducted a PET study with F-florbetapir in a cohort of 12 right-handed patients diagnosed with PPA: 3 patients with semantic-variant PPA, 5 with nonfluent PPA, 1 with LPA, and 3 unclassifiable patients. We evaluated amyloid deposition between APP groups and 11 patients with typical amnestic AD. RESULTS: Among the 12 patients with PPA syndrome, 8 (66.7%) were considered as amyloid positive. One of the 3 patients with semantic-variant PPA was F-florbetapir positive. In contrast, 4 of the 5 nonfluent-variant PPA, 2 of the 3 unclassifiable cases and the single patient with LPA were F-florbetapir positive. A significantly higher F-florbetapir uptake was observed in PPA F-florbetapir-positive patients compared with typical AD patients. This difference was observed in all regions of interest, except in posterior cingulate and temporal cortex. CONCLUSIONS: These results suggest that F-florbetapir PET may be useful in a routine clinical procedure to improve the reliability of identifying AD pathology in patients with PPA syndrome, with different clinical subtypes of the PPA syndrome.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Beaufils E, Vercouillie J, Vierron E, et al. Amyloid PET Positivity in Different Primary Progressive Aphasia Phenotypes. Clin Nucl Med. 2018. PMID: 29504965. doi:10.1097/RLU.0000000000002018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。